Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Apple Inc.AAPL · Entity 2389 | SVP, Gen'l Counsel, Secretary | June 26, 2009 | July 02, 2009 |
| MOLINA HEALTHCARE, INC.MOH · Entity 3504 | Director | April 01, 2025 | April 02, 2025 |
| ORACLE CORPORCL · Entity 2805 | SVP, Gen'l Counsel,Secretary | October 08, 2007 | October 10, 2007 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Apple Inc.
Report date June 26, 2009 · Filed July 02, 2009
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (ESPP)SEC Table I · non-derivative | Direct | 18,910 |
Reported balance
After 2009-06-26 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2009-06-26 · Grant · Acquired 74 · Balance 18,910 F1: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Apple Inc. Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of December 29, 2008 to June 26, 2009. This transaction is also exempt under Rule 16b-3(c). F2: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on December 29, 2008. |
| Common StockSEC Table I · non-derivative | IndirectHeld by son | 140 |
Reported balance
Holding disclosure · report date 2009-06-26 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 140 |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Apple Inc. Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of December 29, 2008 to June 26, 2009. This transaction is also exempt under Rule 16b-3(c).
F2: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on December 29, 2008.
MOLINA HEALTHCARE, INC.
Report date April 01, 2025 · Filed April 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,383 |
Reported balance
After 2025-04-01 transaction · row 1
1 source rowRow 1 · 2025-04-01 · Grant · Acquired 56 · Balance 6,383 F1: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since Mr. Cooperman will not be seeking re-election at the 2025 annual stockholders' meeting, the value of his grant was prorated for one month to $18,333. The closing price of the Issuer's common stock on April 1, 2025 was $327.71, which resulted in a grant of 56 shares. F3: Represents the closing price of the Issuer's common stock on April 1, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
F2: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since Mr. Cooperman will not be seeking re-election at the 2025 annual stockholders' meeting, the value of his grant was prorated for one month to $18,333. The closing price of the Issuer's common stock on April 1, 2025 was $327.71, which resulted in a grant of 56 shares.
F3: Represents the closing price of the Issuer's common stock on April 1, 2025.
ORACLE CORP
Report date October 08, 2007 · Filed October 10, 2007
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,817 |
Ending reported balance
After 2007-10-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2007-10-08 · Exercise / conversion · Acquired 75,000 · Balance 85,817 Row 2 · 2007-10-08 · Sale · Disposed 75,000 · Balance 10,817 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.88 · Expires 2009-06-04 | Direct | 0 |
Reported balance
After 2007-10-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2007-10-08 · Exercise / conversion · Disposed 75,000 · Balance 0 F1: Option vests 25% annually on anniversary of grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Option vests 25% annually on anniversary of grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2025 Filed Apr 2, 2025 20:53 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 56 | $327.71 | $18,351.76 |
DisclosureSEC source: 0001179929-25-000058 · wk-form4_1743627181.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,383 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since Mr. Cooperman will not be seeking re-election at the 2025 annual stockholders' meeting, the value of his grant was prorated for one month to $18,333. The closing price of the Issuer's common stock on April 1, 2025 was $327.71, which resulted in a grant of 56 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2025. Read SEC document |
| January 01, 2025 Filed Jan 2, 2025 22:16 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 189 | $291.05 | $55,008.45 |
DisclosureSEC source: 0001179929-25-000010 · wk-form4_1735856194.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,327 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2025, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2024, of $291.05. Thus, the grant this quarter for services as a Director is for 189 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2024. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:45 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 161 | $341.91 | $55,047.51 |
DisclosureSEC source: 0001179929-24-000144 · wk-form4_1727901897.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,138 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2024, was $341.91, which resulted in a grant of 161 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2024. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:55 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 188 | $292.16 | $54,926.08 |
DisclosureSEC source: 0001179929-24-000111 · wk-form4_1719953752.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,977 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2024, was $292.16, which resulted in a grant of 188 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2024. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:53 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 136 | $404.20 | $54,971.20 |
DisclosureSEC source: 0001179929-24-000077 · wk-form4_1712091174.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,789 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2024, was $404.20, which resulted in a grant of 136 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2024. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 00:19 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 152 | $361.31 | $54,919.12 |
DisclosureSEC source: 0001179929-24-000018 · wk-form4_1704241131.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,653 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2024, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 29, 2023, of $361.31. Thus, the grant this quarter for services as a Director is for 152 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 29, 2023. Read SEC document |
| October 01, 2023 Filed Oct 2, 2023 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 168 | $327.89 | $55,085.52 |
DisclosureSEC source: 0001179929-23-000120 · wk-form4_1696289238.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,501 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of October 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on September 29, 2023, of $327.89. Thus, the grant this quarter for services as a Director is for 168 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on September 29, 2023. Read SEC document |
| July 01, 2023 Filed Jul 3, 2023 21:00 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 183 | $301.24 | $55,126.92 |
DisclosureSEC source: 0001179929-23-000089 · wk-form4_1688418019.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,333 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2023, of $301.24. Thus, the grant this quarter for services as a Director is for 183 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2023. Read SEC document |
| April 01, 2023 Filed Apr 3, 2023 22:49 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 206 | $267.49 | $55,102.94 |
DisclosureSEC source: 0001179929-23-000056 · wf-form4_168056212664020.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,150 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of April 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on March 31, 2023, of $267.49. Thus, the grant this quarter for services as a Director is for 206 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on March 31, 2023. Read SEC document |
| March 03, 2023 Filed Mar 3, 2023 23:24 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001179929-23-000033 · wf-form4_167788586403203.xml · derivative · entry 3 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2023-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options are fully vested. Read SEC document |
| March 03, 2023 Filed Mar 3, 2023 23:24 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 5,000 | $276.77 | $1,383,829.50 |
DisclosureSEC source: 0001179929-23-000033 · wf-form4_167788586403203.xml · nonDerivative · entry 2 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,944 F1 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $276.60 to $277.055. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| March 03, 2023 Filed Mar 3, 2023 23:24 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionCommon Stock | 5,000 | $33.02 | $165,100.00 |
DisclosureSEC source: 0001179929-23-000033 · wf-form4_167788586403203.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2023 Filed Jan 3, 2023 23:22 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 167 | $330.22 | $55,146.74 |
DisclosureSEC source: 0001179929-23-000013 · wf-form4_167278811986106.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,944 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 30, 2022, of $330.22. Thus, the grant this quarter for services as a Director is for 167 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 30, 2022. Read SEC document |
| October 01, 2022 Filed Oct 5, 2022 02:05 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 167 | $329.84 | $55,083.28 |
DisclosureSEC source: 0001179929-22-000158 · wf-form4_166493512353178.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,777 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of October 1, 2022 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on September 30, 2022, of $329.84. Thus, the grant this quarter for services as a Director is for 167 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on September 30, 2022. Read SEC document |
| September 08, 2022 Filed Sep 10, 2022 00:05 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 2,500 | $353.00 | $882,500.00 |
DisclosureSEC source: 0001179929-22-000137 · wf-form4_166276829250383.xml · nonDerivative · entry 4 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,610 F1 · price: Represents the actual selling price per share of all 2,500 shares. Read SEC document |
| September 08, 2022 Filed Sep 10, 2022 00:05 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionCommon Stock | 2,500 | $33.02 | $82,550.00 |
DisclosureSEC source: 0001179929-22-000137 · wf-form4_166276829250383.xml · nonDerivative · entry 3 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,110 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 07, 2022 Filed Sep 10, 2022 00:05 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001179929-22-000137 · wf-form4_166276829250383.xml · derivative · entry 6 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 2,500 shares Expires 2023-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options are fully vested. Read SEC document |
| September 07, 2022 Filed Sep 10, 2022 00:05 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001179929-22-000137 · wf-form4_166276829250383.xml · derivative · entry 5 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 2,500 shares Expires 2023-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options are fully vested. Read SEC document |
| September 07, 2022 Filed Sep 10, 2022 00:05 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 2,500 | $346.00 | $865,000.00 |
DisclosureSEC source: 0001179929-22-000137 · wf-form4_166276829250383.xml · nonDerivative · entry 2 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,610 F1 · price: Represents the actual selling price per share of all 2,500 shares. Read SEC document |
| September 07, 2022 Filed Sep 10, 2022 00:05 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionCommon Stock | 2,500 | $33.02 | $82,550.00 |
DisclosureSEC source: 0001179929-22-000137 · wf-form4_166276829250383.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,110 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2022 Filed Jul 1, 2022 23:40 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 194 | $282.90 | $54,882.60 |
DisclosureSEC source: 0001179929-22-000104 · wf-form4_165671879914036.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,610 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2022, the first day of the quarter, was $282.90, which resulted in a grant of 194 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2022. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 00:42 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 162 | $339.41 | $54,984.42 |
DisclosureSEC source: 0001179929-22-000073 · wf-form4_164911931945795.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,416 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2022, the first day of the quarter, was $339.41, which resulted in a grant of 162 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2022. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 00:31 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 173 | $318.08 | $55,027.84 |
DisclosureSEC source: 0001179929-22-000015 · wf-form4_164125625694179.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,254 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2022 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2021, of $318.08. Thus, the grant this quarter for services as a Director is for 173 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2021. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 00:52 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $33.02 | $0.00 |
DisclosureSEC source: 0001179929-21-000181 · wf-form4_163711034156715.xml · derivative · entry 3 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 5,000 shares Expires 2023-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options are fully vested. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 00:52 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 5,000 | $309.13 | $1,545,650.00 |
DisclosureSEC source: 0001179929-21-000181 · wf-form4_163711034156715.xml · nonDerivative · entry 2 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,081 F1 · price: This transaction was executed in multiple trades at prices ranging from $307.81 to $311.25. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 00:52 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionCommon Stock | 5,000 | $33.02 | $165,100.00 |
DisclosureSEC source: 0001179929-21-000181 · wf-form4_163711034156715.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,081 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 00:48 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 203 | $271.51 | $55,116.53 |
DisclosureSEC source: 0001179929-21-000151 · wf-form4_163339492291564.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,081 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2021, the first day of the quarter, was $271.51, which resulted in a grant of 203 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2021. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 21:06 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 215 | $256.05 | $55,050.75 |
DisclosureSEC source: 0001179929-21-000119 · wf-form4_162525997623281.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,878 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2021, the first day of the quarter, was $256.05, which resulted in a grant of 215 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 3, 2021 00:05 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 234 | $235.48 | $55,102.32 |
DisclosureSEC source: 0001179929-21-000073 · wf-form4_161740823472054.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,663 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2021, the first day of the quarter, was $235.48, which resulted in a grant of 234 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2021. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 00:45 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 259 | $212.68 | $55,084.12 |
DisclosureSEC source: 0001179929-21-000014 · wf-form4_160980753463638.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,429 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2021 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2020, of $212.68. Thus, the grant this quarter for services as a Director is for 259 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2020. Read SEC document |
| November 04, 2020 Filed Nov 7, 2020 00:01 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 3,243 | $217.50 | $705,352.50 |
DisclosureSEC source: 0001179929-20-000146 · wf-form4_160470729890919.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,170 F1 · price: Represents the actual selling price per share of all 3,243 shares. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 22:11 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 292 | $188.18 | $54,948.56 |
DisclosureSEC source: 0001179929-20-000131 · wf-form4_160167667045145.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,413 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2020 was $188.18, which resulted in a grant of 292 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2020. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 23:24 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 307 | $179.12 | $54,989.84 |
DisclosureSEC source: 0001179929-20-000099 · wf-form4_159373225564634.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,121 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2020 was $179.12, which resulted in a grant of 307 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2020. Read SEC document |
| April 01, 2020 Filed Apr 4, 2020 00:29 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 419 | $131.16 | $54,956.04 |
DisclosureSEC source: 0001179929-20-000065 · wf-form4_158596015277978.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,814 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2019-2020 was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2020, the first day of the quarter, was $131.16, which resulted in a grant of 419 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2020. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 23:57 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 405 | $135.69 | $54,954.45 |
DisclosureSEC source: 0001179929-20-000010 · wf-form4_157809580349211.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,395 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2019-2020 was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2020 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2019, of $135.69. Thus, the grant this quarter for services as a Director is for 405 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2019. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 502 | $109.48 | $54,958.96 |
DisclosureSEC source: 0001179929-19-000150 · wf-form4_157005885686268.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,990 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate value of the annual equity award to each director in 2019-2020 was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2019, the first day of the quarter, was $109.48, which resulted in a grant of 502 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2019. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 22:15 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 392 | $140.31 | $55,001.52 |
DisclosureSEC source: 0001179929-19-000126 · wf-form4_156219213091255.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,488 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2019-2020 was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2019, the first day of the quarter, was $140.31, which resulted in a grant of 392 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2019. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 22:20 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 4,004 | $155.00 | $620,620.00 |
DisclosureSEC source: 0001179929-19-000100 · wf-form4_155994602694423.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,096 F1 · price: Represents the actual selling price per share of all 4,004 shares. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 23:27 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 380 | $144.70 | $54,986.00 |
DisclosureSEC source: 0001179929-19-000074 · wf-form4_155433402418185.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,100 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate value of the annual equity award to each director in 2018-2019 was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2019, the first day of the quarter, was $144.70, which resulted in a grant of 380 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2019. Read SEC document |
| January 01, 2019 Filed Jan 4, 2019 00:34 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 473 | $116.22 | $54,972.06 |
DisclosureSEC source: 0001179929-19-000013 · wf-form4_154656205357879.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,720 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate value of the annual equity award to each director in 2018-2019 was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2019 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2018, of $116.22. Thus, the grant this quarter for services as a Director is for 473 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2018. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 23:54 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 371 | $148.14 | $54,959.94 |
DisclosureSEC source: 0001179929-18-000177 · wf-form4_153861086140870.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,247 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate value of the annual equity award to each director in 2018-2019 was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2018, the first day of the quarter, was $148.14, which resulted in a grant of 371 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2018. Read SEC document |
| August 14, 2018 Filed Aug 16, 2018 23:45 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 943 | $133.81 | $126,180.57 |
DisclosureSEC source: 0001179929-18-000159 · wf-form4_153446313451448.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,876 F1 · price: Represents the actual selling price per share of all 943 shares. Read SEC document |
| July 01, 2018 Filed Jul 3, 2018 23:03 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 562 | $97.94 | $55,042.28 |
DisclosureSEC source: 0001179929-18-000136 · wf-form4_153065901215671.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,819 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2018-2019 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2018 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 29, 2018, of $97.94. Thus, the grant this quarter for services as a Director is for 562 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on June 29, 2018. Read SEC document |
| April 01, 2018 Filed Apr 4, 2018 00:14 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 678 | $81.18 | $55,040.04 |
DisclosureSEC source: 0001179929-18-000086 · wf-form4_152280086239494.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,257 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of April 1, 2018 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on March 29, 2018, of $81.18. Thus, the grant this quarter for services as a Director is for 678 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on March 29, 2018. Read SEC document |
| January 01, 2018 Filed Jan 3, 2018 01:10 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 717 | $76.68 | $54,979.56 |
DisclosureSEC source: 0001179929-18-000012 · wf-form4_151494180152242.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,804 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2018 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 29, 2017, of $76.68. Thus, the grant this quarter for services as a Director is for 717 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 29, 2017. Read SEC document |
| January 01, 2018 Filed Mar 3, 2018 02:26 UTC Amendment | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 717 | $76.68 | $54,979.56 |
DisclosureSEC source: 0001179929-18-000055 · wf-form4a_152004395428114.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,579 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2018 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 29, 2017, of $76.68. Thus, the grant this quarter for services as a Director is for 717 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 29, 2017. F4 · balance_after: The total amount shown corrects an earlier overstatement of 3,225 shares. Read SEC document |
| November 07, 2017 Filed Nov 7, 2017 23:38 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 4,500 | $78.79 | $354,555.00 |
DisclosureSEC source: 0001179929-17-000224 · wf-form4_151009791754228.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,087 F1 · price: Represents the actual selling price for all 4,500 shares. Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 22:31 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 800 | $68.76 | $55,008.00 |
DisclosureSEC source: 0001179929-17-000195 · wf-form4_150698346539910.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,587 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of October 1, 2017 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on September 29, 2017, of $68.76. Thus, the grant this quarter for services as a Director is for 800 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on September 29, 2017. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 21:49 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 795 | $69.18 | $54,998.10 |
DisclosureSEC source: 0001179929-17-000157 · wf-form4_149929134954781.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,787 F1 · kind: Grant of stock under the Issuer's 2011 Equity Incentive Plan, as amended, in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director in 2017-2018 shall be $220,000, with one quarter of that amount in stock, or $55,000, to be granted on the first day of each quarter based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2017 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2017, of $69.18. Thus, the grant this quarter for services as a Director is for 795 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2017. Read SEC document |
| May 05, 2017 Filed May 5, 2017 23:51 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 7,542 | $65.74 | $495,811.08 |
DisclosureSEC source: 0001179929-17-000101 · wf-form4_149402827177234.xml · nonDerivative · entry 1 COOPERMAN DANIEL · CIK 0001205008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,992 F1 · price: Represents the weighted average selling price with a selling price range between $65.65 and $65.87. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.